Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Illumination Diagnostics is a medical technology company focused on developing a proprietary line of wearable optical devices for non-invasive, continuous monitoring of critical health metrics. Founded by Dr. Theodore Schwartz, a Professor of Neurosurgery, the company's technology addresses unmet needs in brain health, anesthesiology, and sleep medicine by providing real-time data on brain swelling, narcotic toxicity, and sleep architecture. Its flagship platform aims to prevent 'never events' such as unexpected vision loss during surgery and to improve patient outcomes in intensive care settings through early detection of neurological deterioration. By bridging the gap between clinical-grade diagnostics and consumer-friendly wearables, Illumination Diagnostics is positioned to serve both hospital environments and home-based health monitoring markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Illumination.